Resmed Inc. [RMD] stock is trading at $240.75, down -2.59%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RMD shares have gain 1.14% over the last week, with a monthly amount glided 6.59%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Resmed Inc. [NYSE: RMD] stock has seen the most recent analyst activity on September 24, 2024, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $280. Previously, Wolfe Research downgraded its rating to Underperform on September 18, 2024, and kept the price target unchanged to $180. On September 04, 2024, downgrade downgraded it’s rating to Hold. Oppenheimer downgraded its rating to a Perform. Citigroup downgraded its rating to a Neutral. In a note dated October 27, 2023, Morgan Stanley upgraded an Overweight rating on this stock and revised its target price from $180 to $169.
Resmed Inc. [RMD] stock has fluctuated between $132.24 and $255.18 over the past year. Currently, Wall Street analysts expect the stock to reach $214.5 within the next 12 months. Resmed Inc. [NYSE: RMD] shares were valued at $240.75 at the most recent close of the market. An investor can expect a potential drop of -10.9% based on the average RMD price forecast.
Analyzing the RMD fundamentals
Resmed Inc. [NYSE:RMD] reported sales of 4.69B for the trailing twelve months, which represents a growth of 9.01%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.22 and Total Capital is 0.22. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 238.53 points at the first support level, and at 236.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 244.67, and for the 2nd resistance point, it is at 248.60.
Ratios To Look Out For
For context, Resmed Inc.’s Current Ratio is 2.59. Further, the Quick Ratio stands at 1.69, while the Cash Ratio is 0.26. Considering the valuation of this stock, the price to sales ratio is 7.55, the price to book ratio is 7.27 and price to earnings (TTM) ratio is 34.78.
Transactions by insiders
Recent insider trading involved Ghoshal Kaushik, Chief Commercial Officer, SaaS, that happened on Sep 12 ’24 when 5000.0 shares were sold. Officer, Ghoshal Kaushik completed a deal on Sep 12 ’24 to buy 5000.0 shares. Meanwhile, Chief Financial Officer Sandercock Brett sold 1000.0 shares on Sep 09 ’24.
